Glenn R. Mattes, President and CEO at TFF Pharmaceuticals, Inc. (TFFP), sold 83,000 shares at $17.51 ($1.5M) on 2021-01-15, disclosed to the SEC on 2021-01-20.
Open-market sale of $1.5M TFFP by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.00 | 3,000 | $51K | 3.5% |
| 2 | $17.51 | 40,000 | $700K | 48.2% |
| 3 | $17.51 | 40,000 | $700K | 48.2% |
| Total | $17.49 avg | 83,000 | $1.5M | 100% |
| Filing → |
| TFFP | SELL | 2021-03-17 | $852K | — | Filing → |
| TFFP | SELL | 2021-02-18 | $673K | — | Filing → |
| TFFP | SELL | 2020-12-29 | $460K | — | Filing → |